Water for Injection (WFI) is a critical utility with increasing demand for vaccines and therapeutics. Traditionally, WFI production uses distillation, but producers that use such systems want options with lower ownership costs and more sustainability. Reverse osmosis (RO) membrane-based...
Adherence to stringent pharmacopeia standards is paramount for ensuring product quality, safety, and regulatory compliance in pharmaceutical manufacturing. As leaders in drug development and production set the pace for the industry, the significance of water quality for critical utilities...
There are various methods used to produce high purity water for the pharmaceutical and biotech industry. Vapor Compression (VC) distillation plants have seen widespread use in the production of bulk Purified Water (PW) and Water For Injection (WFI). Two...
Efficiently producing Purified Water and Water for Injection is key to making the industry more sustainable While the biopharmaceutical industry’s primary focus is on producing products that improve health, the manufacturing process can be energy-intensive and can produce emissions...
Introduction “Our priority is to provide our customers with the high purity water and steam that is critical to the development and manufacturing of life-saving medications now and for future generations.” —George Gsell, MECO President Nexus Pharmaceuticals, maker of...
A Look at the Cost of Alternative Systems for Producing Water for Injection (WFI) Including Membrane-Based WFI Production Absent Distillation In 2016, the European Pharmacopeia (Ph. Eur.) revised its monograph to allow “distillation or a purification process that is...
